Healthcare in developing nations like India is experiencing fast changes. The growing population in India is probably going to prompt expanded interest in medical devices. Also, expanding technological advances is quickening the market development empowering surgical equipment to acquire distinctive features. Futura Surgicare is one of the trusted brands for wound closure products that understands and caters to surgeons' requirements and provides quality products with a significant focus on research and development. Headquartered in Bengaluru, Futura Surgicare is one of the oldest and most recognized suture manufacturing companies and suture exporters in India.
Futura Surgicare was established in 1994, and the organization’s purpose has been to provide healthcare professionals and hospitals with products tailored to meet the specific needs of the wound closure segment. Dolphin Sutures has a different portfolio of wound closure products, including a full range of surgical sutures. As a suture manufacturer, the organization has an experience of nearly 25 years in manufacturing, marketing and exporting surgical sutures. Dolphin Sutures is a pioneer suture company in the sutures industry in India.
The organization is the 1st Indian suture manufacturing company to manufacture synthetic absorbable medical sutures like Polyglycolic Acid Sutures and Polyglactin 910 suture. Dolphin Sutures is also the first Indian brand to launch Triclosan coated antibacterial Polyglactin 910 sutures in India. It offers a full range of medical sutures including general sutures, ophthalmic and cardiovascular sutures and provides customization and OEM services.
The organization also offers a strong product portfolio including sutures, suture kits, surgical mesh, skin stapler, microporous paper tapes and bone wax. In 2003, Futura Surgicare launched the Dolphin Sutures brand of surgical sutures. Within 10 years, the company has expanded its portfolio of wound closure devices by launching surgical mesh with the brand name Dolphin Mesh, skin staplers with the brand name Dolphin Stapler and surgical tapes with the brand name Dolphin Tape. The company’s manufacturing facility is equipped with a Class 10,000 manufacturing area, in-house ETO sterilizers for sterile sutures and houses a fully equipped Quality Control Laboratory. The facility is run by professional, qualified and expert staff.
“We are currently certified with CE, ISO 13485, ISO 9001:2008 and WHO: GMP and the products are registered and certified to use in many countries across the world.” says Abhijith Sagar, Director, Futura Surgicare. The certificates ensure that the systems, practices and management is tuned to produce high-quality products meeting all regulatory standards. For this reason, the organization sources the raw materials only from highly specialized, established and world leaders of the USA, UK, Germany, Japan & Korea.
Futura Surgicare has established protocols, standard operating procedures, sterilization procedures and subsequent stability studies to ensure that sutures are made for high quality and remain during the entire shelf life. The organization has exported products to more than 50 countries across Asia, Europe, Australia and Africa. The company’s customers include medical colleges, multi-speciality hospitals, government hospitals, defence establishments and companies importing under the OEM label. “We continuously evaluate our suture quality and receive feedback from surgeons for improving our product standards and providing better outcomes”, concludes Abhijith.